Project Details
| Status | Active |
|---|---|
| Effective start/end date | 8/9/24 → 8/9/27 |
Funding
- Medpace Clinical Research LLC (Prot #CF33-CD19-101 // Prot #CF33-CD19-101)
- Imugene Limited (Prot #CF33-CD19-101 // Prot #CF33-CD19-101)
Prot #CF33-CD19-101: A Phase I, Dose Escalation and Dose Expansion, Safety and Tolerability Study of onCARlytics (CF33-CD19), Administered Intravenously or Intratumorally in Combination with Blinatumomab in Adults with Advanced or Metastatic Solid Tumor
- Mahalingam, Devalingam (PD/PI)
Project: Research project